期刊文献+

B细胞非霍奇金淋巴瘤患者外周血CD4+CD25high CD127low调节性T细胞水平及其临床意义 被引量:1

Detection of peripheral blood CD4+ CD25high CD127low regulatory T cells in patients with B-cell non-Hodgkin lymphoma and its clinical significance
原文传递
导出
摘要 目的 探讨外周血CD4+ CD25high CD127low调节性T细胞(Treg细胞)在B细胞非霍奇金淋巴瘤(B-NHL)患者外周血中表达水平及其临床意义.方法 采用流式细胞术检测100例初诊B-NHL患者及50名健康对照者外周血CD4+ CD25high CD127low Treg细胞表达水平,进行统计学分析.结果 健康对照者外周血CD4+ CD25high CD127low Treg细胞中位表达水平为5.00%,初诊B-NHL患者为7.20%,两者之间差异具有统计学意义(P< 0.001).男性患者外周血CD4+ CD25high CD 127low Treg细胞水平高于女性患者(P<0.01),乳酸脱氢酶(LDH)增高患者外周血CD4+ CD25high CD127low Treg细胞水平高于LDH正常患者(P<0.01),Ⅲ~Ⅳ期患者外周血CD4+C D25high CD 127low Treg细胞水平较Ⅰ~Ⅱ期患者增高(P<0.01),有B症状患者外周血CD4+ CD25high CD127low Treg细胞水平高于无B症状患者(P<0.01).而不同年龄、国际预后指数评分、有无大包块患者之间外周血CD4+ CD25high CD 127low Treg细胞水平差异均无统计学意义(均P>0.05).结论 B-NHL患者体内存在免疫抑制,在男性、LDH增高、有B症状及晚期患者中CD4+ CD25high CD127low Treg细胞水平明显增高.检测其水平对于判断B-NHL的预后有一定价值. Objective To detect peripheral blood level of CD4+ CD25high CD127low regulatory T (Treg) cells in patients with B cell non-Hodgkin lymphoma (B-NHL) and to explore its clinical significance.Methods The levels of peripheral blood CD4+ CD25high CD127low Treg cells of 100 newly diagnosed patients with B-NHL and 50 healthy adults were detected and analyzed by flow cytometry.Results The levels of peripheral blood CD4+ CD25high CD12low Treg cells were 5.00 % and 7.20 % in healthy adults and newly diagnosed B-NHL patients,respectively.The difference was statistically significant (P 〈 0.001).The level of peripheral blood CD4+ CD25high CD127low Treg cells was significantly higher in the male patients than that in the female (P 〈 0.01).The level of peripheral blood CD4+ CD25high CD127low Treg cells was significantly higher in elevated LDH patients than that in normal LDH patients (P 〈 0.01).The level of peripheral blood CD4+ CD25high CD127low Treg cells in stage Ⅲ-Ⅳ patients was significantly higher than that in stage Ⅰ-Ⅱ patients (P 〈 0.01).The level of peripheral blood CD4+ CD25high CD127low Treg cells in B symptom patients was significantly higher than that in no B symptom patients (P 〈 0.01).There was no significant relationship between the level of peripheral blood Treg cells and age,IPI score,bulky disease or pathologic subtype (all P 〉 0.05).Conclusions B-NHL patients were in an immunosuppresive statue.Male,elevated LDH level,B symptom and Ⅲ-Ⅳ stage were correlated with higher level of peripheral blood CD4+ CD25high CD127low Treg cells.Level of peripheral blood Treg cells may be a useful prognostic factor for B-NHL.
出处 《白血病.淋巴瘤》 CAS 2014年第12期737-739,共3页 Journal of Leukemia & Lymphoma
基金 山西省科技攻关项目(20100311099-1)
关键词 淋巴瘤 非霍奇金 CD4+ CD25highCD127low调节性T细胞 Lymphoma, non-Hodgkin CD4+ CD25high CD127low regulatory T cells
  • 相关文献

参考文献16

  • 1王德林,朱军.恶性淋巴瘤的血清肿瘤标志[J].白血病.淋巴瘤,2005,14(6):335-338. 被引量:8
  • 2Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-receptor alpha-chains (CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol,1995,155:1151-1164.
  • 3Lim HW,Hillsamer P,Banham AH,et al.Direct sulppression of B cells by CD4+ CD25+ regulatory T cells[J].J Immunol,2005,175:4180-4183.
  • 4Ioannides CG,Whiteside TL.T cell recognition of human tumors:implications for molecular immunotherapy of cancer[J].Clin Immunol Immunopathol,1993,6691-106.
  • 5Curiel TJ,Coukos G,Zou L,et al.Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival[J].Nat Med,2004,10:942-949.
  • 6Liyanage UK,Moore TT,Joo HG,et al.Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma[J].J Immunol,2002,169:2756-2761.
  • 7Ormandy LA,Hillemann T,Wedemeyer H,et al.Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma[J].Cancer Res,2005,65:2457-2464.
  • 8张颖,于晓峰.调节性T细胞与消化道肿瘤[J].国际消化病杂志,2008,28(1):72-75. 被引量:2
  • 9Woo EY,Chu CS,Goletz TJ,et al.Regulatory CD4+ CD25+T cells in tumors from patients with early stage non-small cell lung cancer and late stage ovarian cancer[J].Cancer Res,2001,61:4766-4772.
  • 10程小珍,韩福才,韩存芝,乔丽娟.CD4^+CD25^+调节性T细胞在晚期肺癌患者中的表达及其免疫抑制作用[J].山西医科大学学报,2008,39(2):160-161. 被引量:3

二级参考文献70

  • 1刘陶文,陈煌基.肿瘤相关物质群(TSGF)联合检测的临床应用研究[J].华夏医学,2004,17(3):293-297. 被引量:8
  • 2王德林,朱军.恶性淋巴瘤的血清肿瘤标志[J].白血病.淋巴瘤,2005,14(6):335-338. 被引量:8
  • 3吴鹏强,赵春燕,韩丽英.淋巴瘤患者血清乳酸脱氢酶检测的临床意义[J].泸州医学院学报,2006,29(1):22-23. 被引量:10
  • 4刘莉,姚军霞,丁乾,黄士昂.非霍奇金淋巴瘤患者外周血CD4^+CD25^(high)调节性T细胞研究[J].中国实验血液学杂志,2006,14(1):119-122. 被引量:30
  • 5Itoh M,Takahashi T,Sakaguchi N,et al.Thymus and autoimmunity:production of CD25^+ CD4^+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.J Immunol,1999; 162:5317 - 5326
  • 6Baecher-Allan C,Brown JA,Freeman GJ,et al.CD4^+ CD25high regulatory cells in human peripheral blood.J Immunol,2001; 167:1245 - 1253
  • 7Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.J Immunol,1995; 155:1151 -1164
  • 8Seo N,Hayakawa S,Takigawa M,et al.Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4^+ Tregulatory cells and systemic collapse of antitumour immunity.Immunology,2001 ;103:449 -457
  • 9Horwitz DA,Zheng SG,Gray JD.The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4^+CD25^+ and CD8^+ regulatory T cell subsets.J Leukoc Biol,2003;74:471 -478
  • 10Piccirillo CA,Shevach EM.Cutting edge:control of CD8^+ T cell activation by CD4^+ CD25^+ immunoregulatory cells.J Immunol,2001 ;167:1137 - 1140

共引文献41

同被引文献31

  • 1Wu W, Wan J, Xia R, et al. Functional role of regulatory T cells in B cell lymphoma and related mechanisms [J]. Int J Clin Exp Pathol, 2015, 8(8) : 9133-9139.
  • 2Bhattacharya K, Chandra S, Mandal C. Critical stoichiometfic ratio of CD4 CD25+ FoxP3+ regulatory T cells and CD4* CD25- responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia[J]. Immunology, 2014, 142( 1 ) : 124-139.
  • 3Vahl JC, Drees C, Heger K, et al. Continuous T cell receptor signals maintain a functional regnlatory T cell pool [J]. Immunity, 2014, 41 (5) : 722-736.
  • 4Lal G, Bromberg JS. Epigenetic mechanisms of regulation of Foxp3 expression [J]. Blood, 2009, 114 (18): 3727-3735.
  • 5Lal G, Bromberg JS. Epigen etic mechanisms of regulation of Foxp3 expression [J]. Blood, 2009, 114 (18): 3727-3735.
  • 6Ichiyama K, Yoshida H, Wakabayashi Y, et al. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat [J]. J Biol Chem, 2008, 283 (25): 17003-17008.
  • 7Janson PC, Winerdal ME, Marits P, et al. FOXP3 promoter demethylation reveals the committed Treg population in humans [J]. PLoS One, 2008, 3 (2): e1612.
  • 8Baron U, Floess S, Wieczorek G, et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells [J]. Eur J Immunol, 2007, 37 (9): 2378-2389.
  • 9Ngalamika O, Liang G, Zhao M, et al. Peripheral whole blood FOXP3 TSDR methylation: a potential marker in severity assessment of autoimmune diseases and chronic infections [J]. Immunol Invest, 2015, 44(2) : 126-136.
  • 10Lal G, Zhang N, van der Touw W, et al. Epigenetic regulation of Foxp3 expression in regulatory T ceils by DNA methylatian [J]. J Immunol, 2009, 182( 1 ) : 259-273.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部